Selexipag in pulmonary arterial hypertension: a comprehensive review.

被引:0
|
作者
Dakwa, David S. [1 ]
Mella, Lisa [1 ]
Mella, Natalie [1 ]
Poulakos, Mara N. [1 ]
机构
[1] Palm Beach Atlantic Univ, W Palm Beach, FL USA
来源
PHARMACOTHERAPY | 2016年 / 36卷 / 12期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
500
引用
收藏
页码:E301 / E301
页数:1
相关论文
共 50 条
  • [31] Transition from selexipag to oral treprostinil in a patient with pulmonary arterial hypertension
    Oriaku, Ifeoma
    Patel, Amol
    Safdar, Zeenat
    PULMONARY CIRCULATION, 2020, 10 (01)
  • [32] DEVELOPMENT OF SERONEGATIVE HYPERTHYROIDISM IN A PEDIATRIC PATIENT ON SELEXIPAG FOR PULMONARY ARTERIAL HYPERTENSION
    Rubio, Dalhila Solorzano
    Canter, Ryan
    Hamaker, Mark
    Murray, Mary
    Jelley, Hannah
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 130 - 131
  • [33] TRANSITION FROM SELEXIPAG TO ORAL TREPROSTINIL IN A PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
    Patel, Amol
    Safdar, Zeenat
    CHEST, 2018, 154 (04) : 1023A - 1024A
  • [34] Pulmonary arterial hypertension: selexipag Selective prostacyclin receptor agonist orally
    Lobo Marquez, Lilia Luz
    Bevacqua, Raul J.
    INSUFICIENCIA CARDIACA, 2019, 14 (01) : 34 - 44
  • [35] Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension
    Parikh, Kishan S.
    Doerfler, Sean
    Shelburne, Nicholas
    Kennedy, Karla
    Whitson, Jordan
    Dahhan, Talal
    Fortin, Terry
    Rajagopal, Sudarshan
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 75 (04) : 299 - 304
  • [36] EXPERIENCE OF USING THE DRUG SELEXIPAG IN THE TREATMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
    Karelkina, E. V.
    Goncharova, N. S.
    Simakova, M. A.
    Moiseeva, O. M.
    KARDIOLOGIYA, 2020, 60 (04) : 36 - 42
  • [37] Transition From Oral Treprostinil to Selexipag in a Patient With Pulmonary Arterial Hypertension
    Verlinden, Nathan J.
    Walter, Claire
    Kanwar, Manreet
    Raina, Amresh
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (07) : 764 - 765
  • [38] SELEXIPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION - AN UPDATED META-ANALYSIS
    Azevedo, Taina
    Armelin, Larissa
    Pereira, Jussara
    Gauza, Mateus De Miranda
    Fernandes, Amanda
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1903 - 1903
  • [39] Oral Selexipag versus Inhaled Treprostinil Effect on Pulmonary Arterial Hypertension
    Nguyen, J. Q.
    Teklu, Y.
    Wu, S.
    Kolaitis, N. A.
    De Marco, T.
    Fanous, S. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S427 - S427
  • [40] Selexipag, an Oral Prostacyclin-Receptor Agonist for Pulmonary Arterial Hypertension
    Baker, William L.
    Darsaklis, Konstadina
    Singhvi, Aditi
    Salerno, Edward L.
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (06) : 488 - 495